TKI treatment for chronic myeloid leukaemia
14 Jul 2011
TKI treatment for chronic myeloid leukaemia
Dasatinib therapy for CML patients unsuitable for imatinib
Development of lenvatinib for thyroid cancer
Role of vemurafenib in melanoma treatment
The changing landscape of melanoma therapies: indications of better patient outcome
Standard of care for ovarian cancer
Treatment options for ovarian cancer
2011 Gianni Bonadonna Breast Cancer Award and ASCO breast highlights
ASCO 2011: Developments in ovarian cancer therapy
Treatment options for prostate cancer
Investigating metabolism for cancer therapy
MD Anderson Institute of Personalised Cancer Therapy